Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Disease recurrence, Drug ineffective, SARS-CoV-2 test
Clinical narrative: 2nd time having COVID for male 20; tested positive; tested positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 03Aug2022, outcome "recovered" and all described as "tested positive"; DISEASE RECURRENCE (medically significant), outcome "unknown", described as "2nd time having COVID for male 20". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: 2nd time having COVID for male 20; (03Aug2022) Positive, notes: 3 out of 9 of us tested positive.  Clinical Information- Reporter was reporting any issues (side effects, complaints, etc.) with the product. Reported issue occur after use of the product. Event information: Event experienced: Rebounded. Admission to hospital due to the event: No. Still experienced: Fine now. Event experienced: Nasal congestion. Admission to hospital due to the event: No. Still experienced: Fine now. Event experienced: Body aches. Admission to hospital due to the event: No. Still experienced: Fine now. Event experienced: Low grade fever, 99.3. Admission to hospital due to the event: No. Still experienced: Fine now. Event experienced: Low energy. Admission to hospital due to the event: No. Any treatment received: No. Still experienced: Fine now. Event experienced: Foggy mind. Admission to hospital due to the event: No. Any treatment received: No. Still experienced: Fine now. Ritonavir (Paxlovid). Dosage and how often taken (for example, 20 mg once a day, 10 mg twice a day): 10 mg 2x a day. Still taking: No. Other product(s) that were taken together with those indicated above: Yes. Name of additional product: Day/night Nyquill tablets. Dates started: 05Aug2022 stopped 10Aug. Still taking: No Name of additional product: rebound Sat am 13Aug2022. Ibuprophen Day/night Nyquill tablets. Lost taste and smell after rebounding on 16Aug2022 used Flonase and to flush sinuses. Finally tested negative on Saturday 20Aug2022 was attending a small family gathering Friday 30Jul for a week. 3 out of 9 of us tested positive on Wednesday 03Aug. none of the other 6 tested positive. Male 20 fully vaccinated and 1 boosted felt fine after 4 days. Individual female 65 fully vaccinated (Pfizer) and 2 booster (Pfizer) recovered w/o Paxlovid. 2nd time having COVID for male 20 and female 65. Myself (Moderna) vaccinated w/o 1 booster, first time getting COVID. Paxlovid helped but 4 days after completing course COVID rebound and felt worse than when I first tested positive on03Aug.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.